Co-Diagnostics, Inc. Common Stock Shares Outstanding

Quick Answer

Co-Diagnostics, Inc. reported Common Stock Shares Outstanding of 2.10 million shares for the year ending 2025.

  • Co-Diagnostics, Inc. showed an increase of +6,983,336.7% in Common Stock Shares Outstanding from 2025 to 2025.
  • This data is from Co-Diagnostics, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
  • XBRL data for this metric is available from 2016 to 2025 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 11 years of available data (2016 to 2025), Co-Diagnostics, Inc.'s Common Stock Shares Outstanding has declined by 78.8%.
  • Historical annual values: Fiscal year 2025: 2.10 million shares | Fiscal year 2025: 30 shares | Fiscal year 2024: 1.10 million shares | Fiscal year 2023: 31.26 million shares | Fiscal year 2022: 30.87 million shares | Fiscal year 2021: 33.82 million shares | Fiscal year 2020: 28.56 million shares | Fiscal year 2019: 17.34 million shares | Fiscal year 2018: 12.92 million shares | Fiscal year 2017: 12.32 million shares | Fiscal year 2016: 9.88 million shares.
  • Data sourced from SEC EDGAR public filings as of June 19, 2026.

Last verified: